Aerovate Therapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Aerovate Therapeutics (AVTE) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Aerovate Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aerovate Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Aerovate Therapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $2.4M | 787k | 3.00 |
| 2024-09-30 | $668k | 334k | 2.00 |
| 2024-06-30 | $86k | 52k | 1.66 |
| 2024-03-31 | $777k | 26k | 29.57 |
| 2023-12-31 | $793k | 35k | 22.63 |
| 2023-09-30 | $259k | 19k | 13.57 |
| 2023-06-30 | $566k | 33k | 17.15 |
| 2022-12-31 | $65k | 2.2k | 29.50 |
| 2022-06-30 | $0 | 7.9k | 0.00 |
| 2022-03-31 | $136k | 7.6k | 17.99 |